Alnylam Pharmaceuticals (ALNY) Research & Development (2009 - 2026)
Alnylam Pharmaceuticals (ALNY) recorded Research & Development of $408.54 million in Q3 2026, up 13.9% from $358.81 million a year earlier but down 1.1% from the prior quarter.
Powered by 
Analysis
Alnylam Pharmaceuticals (ALNY) Research & Development (2009 - 2026) Analysis & Trends
On a TTM basis, Alnylam Pharmaceuticals' Research & Development came in at $1.56 billion as of Sep 30, 2026, up 24.9% year-over-year; for FY2025, it came in at $1.32 billion, up 17.2% from FY2024.
- Annual Research & Development has increased for five straight years, with a five-year compound annual growth rate of 15.0% (FY2020 to FY2025).
- Across earlier years, Research & Development came in at $1.13 billion in FY2024 (+12.1%), $1 billion in FY2023 (+13.7%), $883.02 million in FY2022 (+11.5%) and $792.16 million in FY2021 (+21.0%).
- Quarterly Research & Development has ranged from $169.89 million in Q1 2022 to $413.13 million in Q2 2026 over the past five years.
- On a year-over-year basis, Research & Development has increased for 18 consecutive quarters, with growth averaging 19.7% over the last eight quarters.
- Peak year-over-year performance for Research & Development in the last five years was growth of 37.6% in Q1 2026, against a decline of 8.6% in Q1 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at $413.13 million (Q2 2026), $364.87 million (Q1 2026) and $372.22 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 4.25 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 4.65 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 2.57 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 4.54 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 3.89 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 2.11 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 1.61 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 3.02 Bn |
| 10 | Alnylam Pharmaceuticals | 20.30 Bn | 7.49 Bn | 1.10 Bn | 408.54 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 408.54 Mn |
| Jun 30, 2026 | 413.13 Mn |
| Mar 31, 2026 | 364.87 Mn |
| Dec 31, 2025 | 372.22 Mn |
| Sep 30, 2025 | 358.81 Mn |
| Jun 30, 2025 | 323.62 Mn |
| Mar 31, 2025 | 265.12 Mn |
| Dec 31, 2024 | 300.17 Mn |
| Sep 30, 2024 | 270.93 Mn |
| Jun 30, 2024 | 294.14 Mn |
| Mar 31, 2024 | 261.00 Mn |
| Dec 31, 2023 | 272.14 Mn |
| Sep 30, 2023 | 253.18 Mn |
| Jun 30, 2023 | 248.53 Mn |
| Mar 31, 2023 | 230.57 Mn |
| Dec 31, 2022 | 262.04 Mn |
| Sep 30, 2022 | 245.37 Mn |
| Jun 30, 2022 | 205.71 Mn |
| Mar 31, 2022 | 169.89 Mn |
| Dec 31, 2021 | 229.05 Mn |
API Access
Alnylam Pharmaceuticals Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=ALNY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "ALNY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=ALNY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();